Bio Protocol vs Curve DAO Token — how do they compare? Bio Protocol trades at Rp433.83 (market cap Rp986,63M, Rp162,5M 24h volume), while Curve DAO Token trades at Rp4,421 (market cap Rp6,8T, Rp758,63M 24h volume). The key difference: Curve DAO Token is far larger — about 6892.1× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 1,5B / 3B CRV (51%) for Curve DAO Token. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Curve DAO Token for 60 Days on average.
| BIO | CRV | |
|---|---|---|
Market Cap | Rp986,63M | Rp6,8T |
Volume (24h) | Rp162,5M | Rp758,63M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,5B / 3B CRV (51%) |
Typical Hold Time | 18 Days | 60 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Curve DAO Token (CRV) is trading at Rp4,527 with a market cap of Rp6.95 trillion, showing a bullish technical signal driven by strong moving averages. The token is above key support levels with resistance near Rp4,900. No major protocol updates were noted recently. The circulating supply is 1.5 million out of 3 million CRV, with a 51% circulation rate and average hold time of 60 days.
Overall outlook is cautiously optimistic due to bullish technicals, but overbought RSI levels suggest potential near-term pullbacks. Key opportunities include network growth and DeFi adoption, while risks involve high volatility and regulatory uncertainty. Investors should monitor support at Rp4,104.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Curve is a decentralized exchange for stablecoins that uses an Automated Market Maker (AMM) to manage liquidity. It is now synonymous with the decentralized finance (DeFi) phenomenon and has seen significant growth in the second half of 2020.
Read more on CRV →